Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Diabetes Care

• Publication date

  1999-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/DIACARE.22.11.1827PMID 10546015
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Insulin and Sulfonylurea Therapy in NIDDM Patients: Are the Effects on Lipoprotein Metabolism Different Even With Similar Blood Glucose Control?

  1997cited by this paper
• Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study

  1997cited by this paper
• Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study.

  1997cited by this paper
• Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus.

  1997cited by this paper
• The Prognostic Value of Blood Glucose in Diabetic Patients with Acute Myocardial Infarction

  1996cited by this paper
• Dysglycaemia and risk of cardiovascular disease.

  1996cited by this paper
• Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes

  1995cited by this paper
• Long-Term Glycemic Control Relates to Mortality in Type II Diabetes

  1995cited by this paper
• NIDDM and Its Metabolic Control Predict Coronary Heart Disease in Elderly Subjects

  1994cited by this paper
• Attenuated Fibrinolysis and Accelerated Atherogenesis in Type II Diabetic Patients

  1993cited by this paper
• Lipids and Lipoproteins Predicting Coronary Heart Disease Mortality and Morbidity in Patients With Non‐Insulin‐Dependent Diabetes

  1993cited by this paper
• Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type 2 (non-insulin-dependent) diabetic and non-diabetic subjects

  1993cited by this paper
• Insulin Therapy in Type 2 Diabetic Subjects Suppresses Plasminogen Activator Inhibitor (PAI‐1) Activity and Proinsulin‐like Molecules Independently of Glycaemic Control

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• The diabetic heart: metabolic causes for the development of a cardiomyopathy.

  1992cited by this paper
• Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

  1991cited by this paper
• In-Hospital Prognosis of Ppatients With Fasting Hyperglycemia After First Myocardial Infarction

  1991cited by this paper
• Thromboxane biosynthesis and platelet function in type II diabetes mellitus.

  1990cited by this paper
• Effect of different insulin regimens on plasma lipoprotein and apolipoprotein concentrations in patients with non-insulin-dependent diabetes mellitus.

  1990cited by this paper
• Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus.

  1989cited by this paper
• Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction.

  1986cited by this paper
• Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study.

  1980cited by this paper
• Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature.

  1979cited by this paper
• Glucose tolerance and coronary heart disease: Helsinki policemen study.

  1979cited by this paper

• Impact of admission-blood-glucose-to-albumin ratio on all-cause mortality and renal prognosis in critical patients with coronary artery disease: insights from the MIMIC-IV database.

  2025cites this paper
• Prognostic Value of the Glucose-to-Potassium Ratio for Mortality in Critically Ill COVID-19 Patients

  2025cites this paper
• Shifting the Paradigm: How Stress Hyperglycemia Alters the Landscape of Heart Failure Management

  2024cites this paper
• Association of admission blood glucose and in- hospital outcome after Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

  2024cites this paper
• The effect of fasting plasma glucose on in-hospital mortality after acute myocardial infarction in patients with and without diabetes: findings from a prospective, nationwide, and multicenter registry.

  2024cites this paper
• The impact of fasting stress hyperglycemia ratio, fasting plasma glucose and hemoglobin A1c on in-hospital mortality in patients with and without diabetes: findings from the China acute myocardial infarction registry

  2023cites this paper
• Response to Letter to Editor From Tayek and Umpierrez: "New Onset or Stress Hyperglycemia and Mortality Risk".

  2023cites this paper
• Effect of Treatment and Nutrition on Glycemic Variability in Critically Ill Patients

  2022cites this paper
• Admission Blood Glucose and 2-Year Mortality After Acute Myocardial Infarction in Patients With Different Glucose Metabolism Status: A Prospective, Nationwide, and Multicenter Registry

  2022cites this paper
• Stress hyperglycemia ratio and long‐term mortality after acute myocardial infarction in patients with and without diabetes: A prospective, nationwide, and multicentre registry

  2022cites this paper
• Inpatient hyperglycaemia, and impact on morbidity, mortality and re-hospitalisation rates.

  2022cites this paper
• Predictors of Prolonged Mechanical Ventilation Among Patients with Aneurysmal Subarachnoid Hemorrhage After Microsurgical Clipping

  2022cites this paper
• Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy.

  2022cites this paper
• Admission hyperglycemia is associated with reperfusion failure in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis.

  2021cites this paper
• Hyperglycemia Is Associated With Increased Mortality in Critically Ill Patients With COVID-19

  2021cites this paper
• Hyperglycemia is Associated With Increased Mortality in Critically Ill Patients With COVID-19

  2021cites this paper
• Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes

  2021cites this paper
• Long Term Outcome Prediction in Stemi/Nstemi Patients By Means of the Model Consisting of Simple Clinical Parameters

  2021cites this paper
• Outcomes of “Real-World” Insulin Strategies in the Management of Hospital Hyperglycemia

  2021cites this paper
• Admission glucose level and short-term mortality in older patients with acute myocardial infarction: results from the KORA Myocardial Infarction Registry

  2021cites this paper
• Reducing Cardiac Injury during ST-Elevation Myocardial Infarction: A Reasoned Approach to a Multitarget Therapeutic Strategy

  2021cites this paper
• Stress-Induced Hyperglycaemia in Non-Diabetic Patients with Acute Coronary Syndrome: From Molecular Mechanisms to New Therapeutic Perspectives

  2021cites this paper
• Fasting Plasma Glucose Level Independently Predicts the Mortality of Patients with Coronavirus Disease 2019 Infection: A Multicenter, Retrospective Cohort Study

  2020cites this paper
• Impact of Raised Blood Glucose Level on In-Hospital Outcome of Thrombolysed Patients with Acute Myocardial Infarction

  2020cites this paper
• Risk factors for hyperglycemia and hypoglycemia in adults with type 2 diabetes mellitus pharmacologically treated: a quantitative systematic review protocol.

  2020cites this paper
• Is Coronary Artery Disease Inevitable in Type 2 Diabetes? From a Glucocentric to a Holistic View on Patient Management

  2020cites this paper
• Newly diagnosed abnormal glucose tolerance determines post-MI prognosis in patients with hospital related hyperglycaemia but without known diabetes.

  2020cites this paper
• The association between glucose-related variables and plaque morphology in patients with ST-segment elevated myocardial infarction

  2020cites this paper
• The impact of plasma glucose levels on in-hospital and long-term mortality in non-diabetic patients with ST-segment elevation myocardial infarction patients

  2020cites this paper
• An Electronic Health Record-Integrated Computerized Intravenous Insulin Infusion Protocol: Clinical Outcomes and in Silico Adjustment

  2019cites this paper
• Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of General Medicine and Surgery Patients with Type 2 Diabetes Principal Investigator:

  2019cites this paper
• Detection of glucose metabolism disorders in coronary patients enrolled in cardiac rehabilitation: Is glycated haemoglobin useful? Data from the prospective REHABDIAB study

  2018cites this paper
• Impact of glycemic state on hospital outcome in patients with acute coronary syndrome in sohag university hospitals

  2018cites this paper
• Higher admission glycaemia independently of diagnosed or unrecognised diabetes mellitus is a risk factor for failed myocardial tissue reperfusion and higher mortality after primary angioplasty.

  2018cites this paper
• Abbreviations AMI : acute myocardial infarction AVB : atrioventricular block BBB : bundle branch block DM : diabetes mellitus MVT : malignant ventricular tachyarrhythmias STEMI : ST elevation myocardial infarction

  2018cites this paper
• Linagliptin Inpatient Trial : A Randomized Controlled Trial on the Safety and Efficacy of Linagliptin ( Tradjenta ® ) Therapy for the Inpatient Management of General Surgery Patients with Type 2 Diabetes

  2018cites this paper
• L'équilibreglycémique àla phaseaiguëdes syndromescoronaires

  2017cites this paper
• Effect of Yiqihuoxue prescription on myocardial energy metabolism after myocardial infarction via cross talk of liver kinase B1-dependent Notch1 and adenosine 5'-monophosphate-activated protein kinase

  2017cites this paper
• High incidence of abnormal glucose metabolism in acute coronary syndrome patients at a moderate altitude: A sub-Himalayan study

  2017cites this paper
• Effect of Yiqihuoxue prescription on myocardial energy metabolism after myocardial infarction via cross talk of liver kinase B1-dependent Notch1 and adenosine 5'-monophosphate-activated protein kinase.

  2017cites this paper
• Admission blood glucose and 10-year mortality among patients with or without pre-existing diabetes mellitus hospitalized with heart failure

  2017cites this paper
• Association of Risk Factors and Glycemic Status in Hospital Patients of Different Types of Myocardial Infarction in a Tertiary Care Hospital

  2017cites this paper
• Altered fasting glycemia in cardiac patients during in-hospital rehabilitation: impact on short and long-term follow-up

  2017cites this paper
• HbA1c AS A PREDICTOR OF PROGNOSIS FOLLOWING ACUTE CORONARY SYNDROME (ACS) AND ST ELEVATION MYOCARDIAL INFARCTION (STEMI) COMPARED TO FASTING AND ADMISSION GLUCOSE

  2017cites this paper
• Computerized Insulin Order Sets and Glycemic Control in Hospitalized Patients.

  2017cites this paper
• Glycemic control, mortality, and hypoglycemia in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials

  2016cites this paper
• Admission glucose and left ventricular systolic function in non-diabetic patients with acute myocardial infarction

  2016cites this paper
• [Recommendations for the management of emergencies in patients with diabetes, acute metabolic complications of diabetes, and steroid-related hyperglycemia].

  2016cites this paper
• Stress Hyperglycemia as a Prognostic Indicator in Non-Diabetic ST Elevation Myocardial Infarction Patients

  2016influential citation
• Glycemic Control in Coronary Revascularization

  2016cites this paper
• Impact of Admission Glucose on Non-Diabetic Patients with ST-Segment Elevation Myocardial Infarction Treated with Percutaneous Coronary Intervention: A Meta-Analysis.

  2016cites this paper
• The Additive Effects of Type 2 Diabetes Mellitus on Neurobehavioral Functioning of Patients Diagnosed with Myocardial Infarction

  2016cites this paper
• Cerebral Metabolism and the Role of Glucose Control in Acute Traumatic Brain Injury.

  2016cites this paper
• Impact of obesity on hospital complications and mortality in hospitalized patients with hyperglycemia and diabetes

  2016cites this paper
• Recomendaciones de manejo de la diabetes, de sus complicaciones metabólicas agudas y de la hiperglucemia relacionada con corticoides en los servicios de urgencias

  2016cites this paper
• Prevalence of glucometabolic disorders in acute coronary syndrome and their prognostic influence in long term cardiovascular outcome

  2016influential citation
• Acute Coronary Heart Disease is Associated with High Prevalence of Prediabetes in North Indian Population

  2016cites this paper
• Cardiopathie ischémique et infarctus chez le diabétique

  2015cites this paper
• Blood glucose variability: a new metric for interventional cardiology?

  2015cites this paper
• Admission Glucose and Risk of Early Death in Non-Diabetic Patients with ST-Segment Elevation Myocardial Infarction: A Meta-Analysis

  2015cites this paper
• Newly impaired glucose metabolism and prognosis after percutaneous revascularization.

  2015cites this paper
• Hyperglykämiemanagement in der Notaufnahme

  2015cites this paper
• THE EFFECTS OF GLYCAEMIC CONTROL IN CARDIAC PATIENTS UNDERGOING CABG SURGERY

  2015cites this paper
• A guideline for the use of variable rate intravenous insulin infusion in medical inpatients

  2015cites this paper
• Intensive Insulin Therapy versus Conventional Insulin Therapy in Post Myocardial Infarction Left Ventricular Remodelling

  2015cites this paper
• Hyperglycemia in emergency patients – prevalence and consequences: results of the GLUCEMERGE analysis

  2015cites this paper
• A STUDY TO ESTABLISH ASSOCIATION OF HYPERGLYCEMIA AND INPATIENT MORTALITY IN PATIENTS WITH UNDIAGNOSED DIABETES MELLITUS

  2015cites this paper
• Impaired Glucose Tolerance or Newly Diagnosed Diabetes Mellitus Diagnosed during Admission Adversely Affects Prognosis after Myocardial Infarction: An Observational Study

  2015cites this paper
• Frequency of newly diagnosed diabetes mellitus in patients with acute myocardial infarction.

  2014cites this paper
• Impact of admission glycemia and glycosylated hemoglobin A1c on long-term clinical outcomes of non-diabetic patients with acute coronary syndrome.

  2014cites this paper
• Acute-phase glucose fluctuation is negatively correlated with myocardial salvage after acute myocardial infarction.

  2014cites this paper
• Diabetes Mellitus and Glucose as Predictors of Mortality in Primary Coronary Percutaneous Intervention.

  2014cites this paper
• Impact of Admission Hyperglycemia on Postmyocardial Infarction Left Ventricular Remodelling

  2014cites this paper
• Contrôle glycémique informatisé en réanimation

  2014cites this paper
• Low Adiponectin Levels and Increased Risk of T2DM in Patients With Myocardial Infarction

  2014cites this paper
• Effect of an optimized treatment with insulin on platelet reactivity after discharge in patients with an acute coronary syndrome and hyperglycemia.

  2014cites this paper
• РЕКОМЕНДАЦИИ ПО ДИАБЕТУ, ПРЕДИАБЕТУ И СЕРДЕЧНО-СОСУДИСТЫМ ЗАБОЛЕВАНИЯМ.

  2014cites this paper
• Hyperglykämiemanagement in der Klinik

  2014cites this paper
• Diabetes Mellitus and Glucose as Predictors of Mortality in Primary Coronary Percutaneous Intervention

  2014cites this paper
• Hemoglobin A1c is a better predictor of prognosis following the non-ST elevation acute coronary syndrome than fasting and admission glucose

  2014cites this paper
• Influence of admission blood glucose and hemoglobin A1c on outcome of acute myocardial infarction

  2014cites this paper
• One‐Year Mortality in Elderly Adults with Non‐ST‐Elevation Acute Coronary Syndrome: Effect of Diabetic Status and Admission Hyperglycemia

  2014cites this paper
• Efecto del tratamiento optimizado con insulina en la reactividad plaquetaria tras el alta de pacientes hiperglucémicos con síndrome coronario agudo

  2014influential citation
• ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD – Summary

  2014cites this paper
• Low Adiponectin Levels and Increased Risk of Type 2 Diabetes in Patients With Myocardial Infarction

  2014cites this paper
• Ein wichtiges Tool zur Prognosebesserung

  2014cites this paper
• ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of theEuropeanSocietyofCardiology(ESC)anddevelopedincollaboration

  2014cites this paper
• Admission Hyperglycemia Predicts Inhospital Mortality and Major Adverse Cardiac Events After Primary Percutaneous Coronary Intervention in Patients Without Diabetes mellitus

  2014influential citation
• [Diabetes and acute coronary syndromes: a practical approach].

  2013cites this paper
• [ESC guidelines on diabetes, pre-diabetes and diseases of the cardiovascular system developed in cooperation with the EASD].

  2013cites this paper
• How to Manage Hyperglycemia in an Acute Coronary Syndrome Patient

  2013cites this paper
• Clinical decision support systems in the care of hospitalised patients with diabetes

  2013cites this paper
• Prognostic value of stress hyperglycemia for in-hospital outcome in acute coronary artery disease.

  2013cites this paper
• Diabetes e síndromes coronárias agudas: uma abordagem prática

  2013cites this paper
• Unrecognized diabetes and myocardial necrosis: predictors of hyperglycemia in myocardial infarction.

  2013influential citation
• A folyamatos szubkután glükózmonitorizálás szerepe az intenzív terápiában

  2013cites this paper
• [Role of continuous subcutaneous glucose monitoring in intensive care].

  2013cites this paper
• Impact of stress hyperglycemia on in-hospital stent thrombosis and prognosis in nondiabetic patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention

  2013cites this paper
• Admission hyperglycemia in acute myocardial infarction: possible role in unveiling patients with previously undiagnosed diabetes mellitus

  2013cites this paper
• Diabetes subdiagnosticado e necrose miocárdica: preditores de hiperglicemia no infarto do miocárdio

  2013cites this paper